alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.37
 
 FY2008
 Victor Viegas




---



##### 



OBJECTIVES
  ELIGIBILITY
   PLAN ADMINISTRATION




---



##### 



PLAN DEFINITIONS
 Revenue
 Cost of Goods Sold
 Gross Margin (GM)
 Operating Profit (Loss)
 Business Unit Operating Profit (Loss)
 Target Incentive
 MBOs
 /s/
Victor Viegas
    
    March 27, 2008Executive
    
    Date/s/
Janice Passarello
    
    April 16, 2008VP of Human Resources
    
    Date/s/ S M Ambler
    
    April 7, 2008CFO
    
    Date/s/
Jack L Saltich
    
    April 21, 2008Lead
Director
    
    Date




---



##### 



Attachment A
 EXECUTIVE INCENTIVE PLAN STATEMENT OF GOALS FOR YEAR 2008
Victor Viegas
 Percent of Base Salary Payment at Plan:
  Board of Directors Discretionary Multiplier:
 Plan Components:
 A. 100% of your target bonus will be based on Corporate performance as follows
 
    
    (40%)Achieve GAAP Revenue of $42.900M. Achieve GAAP Operating Profit (Loss) of
$(16.100)M. Operating Profit (Loss) includes non cash stock compensation expense.
Operating Profit (Loss) amounts are stated prior to taking account of Executive
Incentive Plan payment amounts. Payment amounts are not pro-rated between matrix
levels.
 Revenue / Operating Profit (Loss) Targets
    
    $38.600M
    
    $40.750M
    
    $42.900M
    
    $45.900M
    
    $48.900M$(12.900)M
    
    
    100
    %
    
    
    110
    %
    
    
    120
    %
    
    
    150
    %
    
    
    200
    %$(14.000)M
    
    
    90
    %
    
    
    100
    %
    
    
    110
    %
    
    
    120
    %
    
    
    150
    %$(16.100)M
    
    
    50
    %
    
    
    80
    %
    
    
    100
    %
    
    
    110
    %
    
    
    120
    %$(16.900)M
    
    
    0
    %
    
    
    50
    %
    
    
    80
    %
    
    
    90
    %
    
    
    90
    %$(17.700)M
    
    
    0
    %
    
    
    0
    %
    
    
    50
    %
    
    
    80
    %
    
    
    80
    %
 
    
    (40%)Corporate Initiatives
 1.
    
    M&A Activity: During FY2008 identify, conduct due diligence,
close, and assimilate at least one acquisition for the corporation that is
greater than $10M in Revenue or greater than $5M in Operating Income.2.
    
    Oracle Implementation: Implement a company-wide ERP system by
upgrading to Oracle 11i in FY2008 from current version. A company-wide system
will help to integrate the majority of the data and processes of the
organization into a unified system and aid in the company attaining an
overarching goal of integrating the businesses more completely for operational
and strategic efficiencies.3.
    
    Increase International presence across all businesses: FY2008
International Revenue is equal to or greater than 45% or $19M of total revenue.4.
    
    During 2008 generate at least 20 non financial or administrative
press releases.
 
    
    (20%)MBOs  to be agreed upon with Board of Directors.
[Federal Register Volume 81, Number 24 (Friday, February 5, 2016)]
[Notices]
[Page 6282]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02182]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Board of Scientific Counselors, National Institute of Neurological 
Disorders and Stroke.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in sections 552b(c)(6), Title 
5 U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Institute of Neurological Disorders and Stroke, including consideration 
of personnel qualifications and performance, and the competence of 
individual investigators, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, National 
Institute of Neurological Disorders and Stroke.
    Date: February 28-March 1, 2016.
    Time: 6:00 p.m. to 11:30 a.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Alan P. Koretsky, Ph.D., Scientific Director, 
Division of Intramural Research, National Institute of Neurological 
Disorders and Stroke, NIH, 35 Convent Drive, Room 6A 908, Bethesda, 
MD 20892, (301) 435-2232, <a href="/cdn-cgi/l/email-protection#f992968b9c8d8a928098b99790979d8ad7979091d79e968f"><span class="__cf_email__" data-cfemail="5932362b3c2d2a322038193730373d2a77373031773e362f">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS).

    Dated: January 29, 2016.
Sylvia Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-02182 Filed 2-4-16; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit C

Expense Summary

For the Period August 1, 2019 to August 31, 2019

Reimbursable Expense Amount

Airfare 5,346.07 $    

Hotel 1,925.95        

Meals 783.84           

Transportation 1,303.68        

Miscellaneous 438.66           

Total Expenses 9,798.20 $    

Case: 19-30088 Doc# 4729-3 Filed: 11/14/19 Entered: 11/14/19 14:52:57 Page 1

of 1
Opinion issued January 27 , 2015

In The 

## Court of Appeals For The 

## First District of Texas

———————————— NO. 01
- 15
- 00017
- CV

——————————— IN RE M.D. MARK, INC . , Relator

Original Proceeding on Petition for Writ of Mandamus

MEMORANDUM OPINION On January 8, 2015, relator, M.D. Mark, Inc., filed a petition for writ of mandamus challenging the trial court’s denial of a motion to appear pro hac vice

. 1 On January 1 4 , 2015, relator filed a motion requesting voluntary dismissal of the

1 The underlying case is M.D. Mark, Inc. v. Penn Virginia Oil & Gas, L.P., Penn Virginia Oil & Gas GP, LLC, Crow Creek Holding Corporation, and Crow Creek Energy, LLC , cause number 2014

- 34393, pending in the 190th District Court of Harris County, Texas, the Honorable Patricia Kerrigan presiding.2

petition , stating that the trial court subsequently signed an order granting the motion. No prior opinion has issued in this original proceeding.
W e grant the motion and dismiss relator’s petition for writ of mandamus

. Cf

. T EX . R. A PP . P. 42.1(a)(1 ). We dismiss any other pending mo tions as moot. PER CURIAM Panel consists of Chief Justice Radack and Justices Bland and Huddle.
<PAGE>
 
                                  EXHIBIT 11.1

                       COMPUTATION OF EARNINGS PER SHARE

                       GEORGIA BANK FINANCIAL CORPORATION
                                 AND SUBSIDIARY

<TABLE>
<CAPTION>
                                                                                   YEAR ENDED
                                                                                   DECEMBER 31, 
                                                        --------------------------------------------------------------
                                                                1997                   1996                  1995
                                                        -------------------    --------------------     --------------
<S>                                                       <C>                  <C>                      <C>
Net income available to common shareholders                      $2,354,925              $1,952,165         $1,405,066
 
Earnings per common share:(1)
    Weighted average number of common
       shares outstanding                                         1,588,828               1,542,368          1,538,025
 
Net income per common share                                      $     1.48              $     1.27         $     0.91
</TABLE>
(1) Adjusted on a comparative basis to reflect reverse stock split (1 for 3)
effected April 21, 1995 and the 15% stock dividend payable September 25, 1996.
Document

Exhibit 10.1

ZSCALER, INC. WAIVER AGREEMENT
This Waiver Agreement (the “Waiver”) is made by Amit Sinha, Ph.d (“Participant”), effective as of the date signed below.


Participant informed the Company he will resign as an employee of Zscaler, Inc. (the “Company”) on October 21, 2022 (the “Employee Resignation Date”). Participant desires to waive any rights to continued vesting of existing Company stock options, restricted stock, restricted stock units and/or and performance-based equity awards (“Equity Awards”) and memorialize an understanding of the transition.


Participant acknowledges and agrees as follows:


1.Participant has submitted his resignation as a member of the Company’s Board of Directors (the “Board”) in accordance with the Company’s Corporate Governance Guidelines, and will await the determination of the Board regarding whether such Board resignation will be accepted or whether Participant shall continue as a member of the Board.


2.Irrespective of the Board’s accepting of Participant’s Board resignation, Participant agrees that any unvested Equity Awards granted prior to the Employee Resignation Date shall be forfeited as of the Employee Resignation Date.


3.Participant’s vested stock option granted on April 6, 2017 shall remain exercisable until the earlier of: (x) the end of the post-termination exercise period related to being a service provider set forth in the option agreement or (y) April 6, 2024, the option’s original expiration date.


4.If Participant continues as a non-employee Board member, then Participant will be eligible for compensation under the Outside Director Compensation Policy, but will not be eligible for an initial restricted stock unit award as a result of his prior and continuing service as a Board member. Participant’s first equity grant as a member of the Board, if any, would be the annual restricted stock grant scheduled at the 2022 Annual Meeting of Stockholders expected to be held in January 2023.


5.This Waiver represents the entire agreement and understanding between the parties as to the subject matter hereof and supersedes all prior or contemporaneous agreements, whether written or oral.


IN WITNESS WHEREOF, this Waiver is entered into as of the Effective Date.


PARTICIPANT    COMPANY


									
	/s/ Amit Sinha
		/s/ Jay Chaudhry

	By: Amit Sinha
		By: Jay Chaudhry

	Date: 10/6/2022
		Date: 10/6/2022
**Exhibit
      32.1**




**CERTIFICATION
      OF CHIEF EXECUTIVE OFFICER**


**PURSUANT
      TO 18 U.S.C. SECTION 1350**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**




In
      connection with the accompanying Annual Report on Form 10-K of Ecoland
      International, Inc. for the fiscal year ending May 31, 2008, I, David A.
      Wallace, Chief Executive Officer of Ecoland International, Inc., hereby certify
      pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief,
      that:




1.  Such
      Annual Report on Form 10-K for the fiscal year ending May 31, 2008, fully
      complies with the requirements of section 13(a) or 15(d) of the Securities
      Exchange Act of 1934; and




2.  The
      information contained in such Annual Report on Form 10-K for the fiscal year
      ending May 31, 2008, fairly presents, in all material respects, the financial
      condition and results of operations of Ecoland International, Inc.




Dated:
      September 15, 2008.




/s/
                David A. WallaceDavid
                A. Wallace, Chief Executive Officer ofEcoland
                International, Inc.
* Pursuant to 5 TH C IR . R. 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 99-10282 Summary Calendar

CARDELL RHETT, JR., also known as Rhett Cardell, Jr., Plaintiff-Appellant,

versus WAYNE SCOTT, DIRECTOR, TEXAS DEPARTMENT OF CRIMINAL JUSTICE, INSTITUTIONAL DIVISION; CHARLES ALEXANDER, Dr.; MAXWELL GARDINER, Dr.; SWARTS, Dr.; B. ALLEN; G. PIERSON; B. CASEL; UTMB MANAGED CARE; SCHERRY MCKELVEY, Defendants-Appellees.

-------------------- Appeal from the United States District Court for the Northern District of Texas

USDC No. 2:96-CV-114

-------------------- November 8, 1999 Before DAVIS, EMILIO M. GARZA, and DENNIS, Circuit Judges.

PER CURIAM: * Cardell Rhett, Texas prisoner # 672730, appeals the district court’s dismissal of his 42 U.S.C. § 1983 action after remand for consideration of his claim that the defendants delayed replacing a necessary knee brace for 14 months. Rhett contends that the defendants’ delay in obtaining the new knee brace constituted deliberate indifference to his serious medical need for a newNo. 99-10282 -2- knee brace. This court’s prior decision which held that Rhett stated a claim of deliberate indifference concerning the 14-month delay in reviewing a new knee brace and that the claim was not frivolous became the “law of the case.” See Young v. Herring , 917 F.2d 858, 861 (5th Cir. 1990). On remand, the district court was bound to accept this determination that Rhett had stated a claim and that the claim was not frivolous. See id. The district court erred in dismissing Rhett’s claim for a second time as frivolous and for failure to state a claim under 28 U.S.C. § 1915A and 42 U.S.C. § 1997e(c). Accordingly, the judgment is REVERSED and the case is REMANDED for further proceedings.

REVERSED AND REMANDED.
Michigan Supreme Court

Lansing, Michigan

Bridget M. McCormack

,

Chief Justice

Brian K. Zahra

David F. Viviano,

Richard H. Bernstein

Elizabeth T. Clement

Megan K. Cavanagh

Elizabeth M. Welch

,

Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

M arch 26 , 2021 

# Order

Clerk March 26 , 2021

161869( 43 )

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

SC: 161869

v COA: 353243

Emmet CC: 19

- 004943

- FH

LUCUS WILLIAM COVEY,

Defendant

- Appellant

.

_______ ______________________________ ___ /

On order of the Chief Justice, the motion of the Emmet County Lakeshore

Association et al. to file a brief amicus curiae is GRANTED. The amicus brief submitted

on March 25 , 2021 , is accepted for filing

.
#### Norman C. Newell and another, Respondents, v. The *City*of Utica, Appellant.

Judgment reversed and a new trial ordered, with costs to abide the event.

Opinion by

Follett, J.

Mem. by Hardin, P. J.
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 Weil, Gotshal & Manges LLP 767 Fifth Avenue New York, NY 10153-0119

EXHIBIT 1J

Rate Case Support Services

Case: 19-30088 Doc# 4602-11 Filed: 11/07/19 Entered: 11/07/19 19:32:50 Page 1

of 7
6/13/2019

Case: 19-30088 Doc# 4602-11 Filed: 11/07/19 Entered: 11/07/19 19:32:50 Page 2

of 7
925 528 9660 reza.jenab@pwc.com

Case: 19-30088 Doc# 4602-11 Filed: 11/07/19 Entered: 11/07/19 19:32:50 Page 3

of 7
Case: 19-30088 Doc# 4602-11 Filed: 11/07/19 Entered: 11/07/19 19:32:50 Page 4

of 7
6/13/2019

Case: 19-30088 Doc# 4602-11 Filed: 11/07/19 Entered: 11/07/19 19:32:50 Page 5

of 7
925 528 9660 reza.jenab@pwc.com

Case: 19-30088 Doc# 4602-11 Filed: 11/07/19 Entered: 11/07/19 19:32:50 Page 6

of 7
Case: 19-30088 Doc# 4602-11 Filed: 11/07/19 Entered: 11/07/19 19:32:50 Page 7

of 7
Long-range 

actuarial 

balance

Annual 

balance in 

75th year

Long-range 

actuarial 

balance

Annual 

balance in 

75th year

Long-range 

actuarial 

balance

Annual 

balance in 

75th year

-3.61 -4.35 0.11 0.08 3% 2%

Estimates based on the intermediate assumptions of the 2023 Trustees Report Office of the Chief Actuary

Social Security Administration

September 15, 2023

Summary Measures and Graphs

Category of Change: Payroll Taxes (including maximum taxable)

Current law

[percent of payroll]

Change from current law

[percent of payroll] Shortfall eliminated

Proposed Provision: E3.12. Beginning in 2031, apply 2 percent payroll tax rate on earnings over the wageindexed equivalent of $400,000 in 2017 (about $696,600 in 2031), with the threshold wage-indexed after 

2031. Provide proportional benefit credit for additional earnings taxed, based on the payroll tax rate applied 

to the additional earnings divided by the full 12.4 percent payroll tax rate.

6.0

8.0

10.0

12.0

14.0

16.0

18.0

20.0

2023 2030 2040 2050 2060 2070 2080 2090

Percent

Year

OASDI Cost Rates and Income Rates

(as a percentage of taxable payroll)

Income rates under current law

Income rates with this provision

Cost rates under current law

Cost rates with this provision

0

100

200

300

400

500

600

2023 2030 2040 2050 2060 2070 2080 2090

Percent

Year

OASDI Trust Fund Ratio

(assets as a percentage of annual expenditures)

Current law With this provision
<PAGE>

                                                                    EXHIBIT 32.1

CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report of Belden & Blake Corporation (the
"Company") on Form 10-K for the period ended December 31, 2003, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned, in the capacities and on the dates indicated below, hereby
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to the knowledge of the undersigned:

         1.       The Report fully complies with the requirements of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         2.       The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.

Date: March 16, 2004                        /s/ John L. Schwager
                                      --------------------------------------
                                       John L. Schwager, Director, President
                                       and Chief Executive Officer

This certification accompanies the Form 10-K and shall not be treated as having
been filed as part of the Form 10-K.
#### In the Matter of the Application of the Staten Island Rapid Transit Company, Respondent, to acquire title to certain real estate of John N. A. Griswold and others, Owners, etc., Appellants.

— Appeal withdrawn and settled.
EXHIBIT 21

             SUBSIDIARIES OF PHARMACEUTICAL MARKETING SERVICES INC.


                                                      
 Subsidiary Name                        Domicile      


PMSI Holdings Limited                   Delaware      
PMSI Scott-Levin Inc.                   New Jersey    
PMSI Finance Limited                    Delaware      
PMSI Database Services Inc.             Delaware      
Source Informatics European             Delaware      
  Holdings Inc.
Source Informatics European             Delaware      
  Holdings LLC
Source Informatics European             Delaware      
  Finance Inc.
PMSI Belgium S.A.                       Belgium       
                                                      
                                                      
Inedi S.A.                              Belgium       
Medical Time Communication Sprl         Belgium       
Source Informatics Belgium N.V.         Belgium       
                                                      
                                                      
Pharma Informatics Inc.                 Delaware
Medical Informatics KK                  Japan         
PMSI Ltd.                               U.K.          
ISIS Ltd.                               U.K.
#### The People of the State of New York ex rel. Angie Codina, Appellant, v Wayne Lamont, Respondent.

[772 NYS2d 806]

Appeal from order, Supreme Court, New York County (John Cataldo, J.), entered on or about April 28, 2003, which denied relator’s petition for a writ of habeas corpus and dismissed the proceeding, unanimously dismissed, without costs.

Relator’s claim of excessive bail is moot since the pretrial bail rulings relator now challenges ceased to have any effect once relator was remanded upon her conviction after retrial in the underlying criminal action *(see People ex rel. England v Warden,*39 AD2d 778 [1972]). Relator’s remaining contentions may not be raised by way of habeas corpus *(People ex rel. Keitt v McMann,*18 NY2d 257, 262 [1966]) and, in any event, they involve matters outside the instant record on appeal. Concur—Mazzarelli, J.P., Saxe, Friedman, Marlow and Gonzalez, JJ.
## Summary Measures and Graphs

- Individual Provisions
- Level of Monthly Benefits

### **Description of Proposed Provision:						B6.1: Provide a 5 percent increase to the monthly benefit amount (MBA) of any beneficiary who is 85 or older at the beginning of 2024 or who reaches their 85th birthday after the beginning of 2024.**

|  |  |
|--|--|
EXHIBIT 21.1



SUBSIDIARIES OF THE REGISTRANT



|                                                |  |                                                             
|----------------------------------------------- |  | ------------------------------------------------------------
|Name of Entity                                  |  | State or Other Jurisdiction of Incorporation or Organization
|APT Technologies, Inc.                          |  | California                                                  
|Cicada Semiconductor, Inc.                      |  | Delaware                                                    
|Multilink Technology Corporation                |  | California                                                  
|Multilink Technology Corporation Israel Ltd.    |  | Israel                                                      
|Multilink Technology GmbH                       |  | Germany                                                     
|Vitesse International Holdings, SRL             |  | Barbados                                                    
|Vitesse International, Inc.                     |  | Barbados                                                    
|Vitesse Manufacturing & Development Corporation |  | Delaware                                                    
|Vitesse Semiconductor Canada Corporation        |  | Canada                                                      
|Vitesse Semiconductor Corporation A/S           |  | Denmark                                                     
|Vitesse Semiconductor GmbH & Co. KG             |  | Germany                                                     
|Vitesse Semiconductor Japan Corporation         |  | Japan                                                       
|Vitesse Semiconductor S.r.l.                    |  | Italy                                                       
|Vitesse Semiconductor Sales Corporation         |  | Delaware